Sign in

CIK 0001721484

  • Emerging growth company

Longeveron Inc.

Sign in to watch
Ticker
LGVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472174146
Phone
+1 305-302-7158
Business address
1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
Former names
LONGEVERON LLC
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 4 Grant or award Chief Scientific Officer acquired 600,000 shares (grant or award)
  4. 4 Shares withheld for taxes Chief Executive Officer gave up 18,046 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Financial Officer gave up 22,505 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Medical Officer gave up 22,505 shares (to pay taxes)
  7. 4 Shares withheld for taxes CTO & SVP of CMC gave up 15,808 shares (to pay taxes)
  8. 4 Shares withheld for taxes General Counsel, Secretary gave up 13,143 shares (to pay taxes)
  9. 4 Grant or award General Counsel, Secretary acquired 250,000 shares (grant or award)
  10. 4 Grant or award Chief Executive Officer acquired 500,000 shares (grant or award)
  11. 4 Grant or award CTO & SVP of CMC acquired 250,000 shares (grant or award)
  12. 4 Grant or award Chief Medical Officer acquired 250,000 shares (grant or award)
  13. 4 Grant or award Chief Financial Officer acquired 250,000 shares (grant or award)
  14. 4 Shares withheld for taxes General Counsel, Secretary gave up 5,611 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Medical Officer gave up 13,145 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Financial Officer gave up 13,145 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Executive Officer gave up 4,740 shares (to pay taxes)
  18. 4 Shares withheld for taxes CTO & SVP of CMC gave up 8,633 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Executive Officer gave up 105,533 shares (to pay taxes)
  20. 3 Insider Initial Statement of Ownership

Page 2 of 13 · 246 filings